At this point in 2007, the Northeast and New England regions are clearly on the right track, with a current combined total investment value (TIV) of nearly $5 billion on the books for active Pharmaceutical-Biotech capital and maintenance (MRO) projects for the year
(All Fields Required)
Site-wide Scheduled Maintenance for April 12, 2025, between 9 A.M. - 9 P.M. CST. During this time, all services will be unavailable periodically throughout the scheduled maintenance window.
×Contact Us
For More Info!